Sergio A Jimenez

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Topics

Mesenchymal Stem Cells

Transforming Growth Factor

Magnetic Nanoparticles

Tyrosine Kinase

Top Venues

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Sonsoles Piera-Velazquez, Simon T Dillon, Xuesong Gu, Towia A Libermann, Sergio A Jimenez
Aptamer proteomics of serum exosomes from patients with Primary Raynaud's and patients with Raynaud's at risk of evolving into Systemic Sclerosis. PloS one 17 (12) (2022)
Sonsoles Piera-Velazquez, Simon T Dillon, Xuesong Gu, Towia A Libermann, Sergio A Jimenez
Aptamer proteomics of serum exosomes from patients with Primary Raynaud's and patients with Raynaud's at risk of evolving into Systemic Sclerosis. PloS one 17 (12) (2022)
Sonsoles Piera-Velazquez, Simon T Dillon, Xuesong Gu, Towia A Libermann, Sergio A Jimenez
Aptamer proteomics of serum exosomes from patients with Primary Raynaud's and patients with Raynaud's at risk of evolving into Systemic Sclerosis. PloS one 17 (12) (2022)
Sonsoles Piera-Velazquez, Simon T Dillon, Xuesong Gu, Towia A Libermann, Sergio A Jimenez
Aptamer proteomics of serum exosomes from patients with Primary Raynaud's and patients with Raynaud's at risk of evolving into Systemic Sclerosis. PloS one 17 (12) (2022)
Sonsoles Piera-Velazquez, Simon T Dillon, Xuesong Gu, Towia A Libermann, Sergio A Jimenez
Aptamer proteomics of serum exosomes from patients with Primary Raynaud's and patients with Raynaud's at risk of evolving into Systemic Sclerosis. PloS one 17 (12) (2022)
Christopher W Wasson, Giuseppina Abignano, Heidi Hermes, Maya Malaab, Rebecca L Ross, Sergio A Jimenez, Howard Y Chang, Carol A Feghali-Bostwick, Francesco Del Galdo
Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH. Annals of the rheumatic diseases 79 (4) (2020)
Peter J Wermuth, Sergio A Jimenez
Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib). PloS one 13 (5) (2018)